Intravenous immunoglobulin treatment with prognosis for the first six months of Guillain–Barré Syndrome in Somalia: Case series

INTRODUCTION: Guillain–Barré Syndrome (GBS) is an acute, immune-mediated polyneuropathy that often leads to severe weakness. Intravenous Immunoglobulin (IVIG) is a proven effective treatment for GBS (class 1 evidence). The clinical course of GBS in individual patients is highly variable and difficul...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidow, Nor Osman, Hassan, Mohamed Sheikh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758282/
https://www.ncbi.nlm.nih.gov/pubmed/36536744
http://dx.doi.org/10.1016/j.amsu.2022.104816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758282/
https://www.ncbi.nlm.nih.gov/pubmed/36536744
http://dx.doi.org/10.1016/j.amsu.2022.104816

Ejemplares similares